Rizzo A.; Ricci A.D.; Bonucci C.; Tober N.; Palloni A.; Frega G.; Brandi G., Experimental HER2- targeted therapies for biliary tract cancer, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2021, 30, pp. 389 - 399 [articolo]
Rizzo A.; Ricci A.D.; Frega G.; Di Federico A.; Brandi G., FGFR inhibitors in elderly patients with advanced biliary tract cancer: an unsolved issue, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2021, 15, pp. 567 - 574 [articolo]
Rizzo A.; Brandi G., First-line Chemotherapy in Advanced Biliary Tract Cancer Ten Years After the ABC-02 Trial: “And Yet It Moves!”, «CANCER TREATMENT AND RESEARCH COMMUNICATIONS», 2021, 27, pp. 1 - 7 [articolo]Open Access
Rizzo A.; Ricci A.D.; Gadaleta-Caldarola G.; Brandi G., First-line immune checkpoint inhibitor-based combinations in unresectable hepatocellular carcinoma: current management and future challenges, «EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY», 2021, 15, pp. 1245 - 1251 [articolo]
Rizzo A.; Ricci A.D.; Brandi G., Futibatinib, an investigational agent for the treatment of intrahepatic cholangiocarcinoma: evidence to date and future perspectives, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2021, 30, pp. 317 - 324 [articolo]
Di Federico A.; Tateo V.; Parisi C.; Formica F.; Carloni R.; Frega G.; Rizzo A.; Ricci D.; Di Marco M.; Palloni A.; Brandi G., Hacking pancreatic cancer: Present and future of personalized medicine, «PHARMACEUTICALS», 2021, 14, Article number: 677, pp. 1 - 19 [articolo]Open Access
Ravaioli Matteo; Brandi Giovanni; Siniscalchi Antonio; Renzulli Matteo; Bonatti Chiara; Fallani Guido; Prosperi Enrico; Serenari Matteo; Germinario Giuliana.; Del Gaudio Massimo; Zanfi Chiara; Odaldi Federica; Bertuzzo Valentina Rosa; Pasqualini Eddi; Maroni Lorenzo; Frascaroli Giacomo; Rossetto Anna; Morelli Maria Cristina; Vizioli Luca; Serra Carla; Sangiorgi Gabriela; D'Errico Antonia; Contedini Federico; Cescon Matteo, Heterotopic segmental liver transplantation on splenic vessels after splenectomy with delayed native hepatectomy after graft regeneration: A new technique to enhance liver transplantation, «AMERICAN JOURNAL OF TRANSPLANTATION», 2021, 21, pp. 870 - 875 [articolo]Open Access
G. Frega, O. Kepp, D. Turchetti, A. Rizzo, M.A. Pantaleo, G. Brandi, Hypothesis on the possible relevance of the immunogenic cell death in the treatment of gestational trophoblastic neoplasms, «TRANSLATIONAL ONCOLOGY», 2021, 14, Article number: 101224, pp. 1 - 3 [articolo]Open Access
Zeneli, A; Brandi, G; Di Pasquale, G; Orlandini, D; De Carolis, P; Bravi, F; Pugliese, F; Poluzzi, E; Catena, F; Giovanardi, F; Valpiani, G; Mantovani, R; Magnanimi, E; Iannone, P., Identifying ethical values for guiding triage decisions during the COVID-19 pandemic: an Italian ethical committee perspective using Delphi methodology, «BMJ OPEN», 2021, 11, Article number: e043239, pp. 1 - 10 [articolo]Open Access
Rizzo A.; Ricci A.D.; Brandi G., IDH inhibitors in advanced cholangiocarcinoma: Another arrow in the quiver?, «CANCER TREATMENT AND RESEARCH COMMUNICATIONS», 2021, 27, pp. 1 - 6 [articolo]Open Access
Rizzo A.; Ricci A.D.; Brandi G., Immune-based combinations for advanced hepatocellular carcinoma: Shaping the direction of first-line therapy, «FUTURE ONCOLOGY», 2021, 17, pp. 755 - 757 [articolo]
Rizzo A.; Ricci A.D.; Lanotte L.; Lombardi L.; Di Federico A.; Brandi G.; Gadaleta-Caldarola G., Immune-based combinations for metastatic triple negative breast cancer in clinical trials: current knowledge and therapeutic prospects, «EXPERT OPINION ON INVESTIGATIONAL DRUGS», 2021, 1, pp. 1-9 - 9 [articolo]
Ricci, A. D.; Rizzo, A.; Brandi, G., In Regard to “A Phase Ib Study of NUC-1031 in Combination with Cisplatin for the First-Line Treatment of Patients with Advanced Biliary Tract Cancer (ABC-08)”, «THE ONCOLOGIST», 2021, 26, pp. e902 - e902 [replica/breve intervento]
Rizzo, A.; Frega, G.; Palloni, A.; Piemontese, A.; Di Federico, A.; Ricci, A.; Carloni, R.; Fabbri, F.; Novelli, M.; Tavolari, S.; Di Marco, M.; Ravaioli, M.; Brandi, G., Intensive follow-up program and oncological outcomes of 278 biliary tract cancer patients after curative intent surgery: A single-center retrospective experience, «ANNALS OF ONCOLOGY», 2021, 32, Article number: P-69, pp. S120 - S120 [articolo]
Ravaioli M.; Piscaglia F.; Cillo U.; Brandi G.; Sessa M.; Germinario G.; Golfieri R.; Cappelli A.; Morelli M.C.; Siniscalchi A.; D'Errico A.; Cescon M.; Iannone P.; Trevisani F., Is the Strongest Level of Medical Evidence Always Required for Guidelines Recommendations?, «LIVER CANCER», 2021, 10, pp. 394 - 395 [replica/breve intervento]Open Access
